CURE4d
Cretostimogene Has Durable Response in BCG-Unresponsive Bladder Cancer
Cretostimogene treatment shows best-in-class durability of response for BCG-unresponsive non-muscle invasive bladder cancer ...
CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates
Updated clinical & translational results: BOND-003 Cohort C- A phase 3, single-arm study of intravesical cretostimogene grenadenorepvec for high-risk BCG-unresponsive non-muscle invasive bladder ...
Business Wire18d
Liberty Global to Present at the NewStreet Research and BCG Future of Connectivity Leaders Conference
DENVER, Colorado--(BUSINESS WIRE)--Liberty Global Ltd. (“Liberty Global”) (NASDAQ: LBTYA, LBTYB and LBTYK) will be presenting at the NewStreet Research and BCG Future of Connectivity Leaders ...